However, IL-12/IFN-γ activation of the IL-23/IL-17 pathway may reduce the severity of inflammatory events, and both pathways may serve as therapeutic targets for the treatment of septicemia-induced acute respiratory distress syndrome [79]. The gene discussed is IL37; the disease is Sepsis.